EDITORIAL SYNOPSIS These studies cast doubt on the validity of the technique of the use of an ion exchange resin by mouth together with l31iodine-labelled albumin intravenously as a method of measuring albumin loss in the alimentary tract.
The use of an ion exchange resin by mouth together with 1311-labelled albumin intravenously has been advocated (Jeejeebhoy and Coghill, 1961; Jeejeebhoy, 1962) as a method for measuring the amount of albumin passing across the intestinal wall into the lumen both in normal and pathological conditions. For the amount of radioactive iodine found in the faeces to be significant as a quantitative measure of albumin leakage, it has to be assumed that the intestinal enzymes are able to liberate all the 1311-iodide from the albumin, and that the resin in the gut is able to adsorb and retain all the radioactivity thus liberated. Investigations were therefore made both in normal humans and in rats, although it is appreciated that intestinal excretion of iodide in rats differs from that in humans (Pastan, 1957) .
The first series of experiments involved the intravenous injection of 1311-albumin and 1251-sodium iodide into both humans and rats. If the method of Jeejeebhoy and Coghill (1961) can be relied upon and a measurable amount of 1311-albumin was passing into the gut, then the ratio of 1311 to 1251 accumulating in the faeces should be higher than the ratio of non-protein 1311 over non-protein 1251 in the plasma at any given time. In practice it is not possible to relate particular faecal samples to the plasma at the time of formation of the faeces because of lack of knowledge of the time between formation and collection. To get over this difficulty faecal and urine radioactivities have been measured over a long enough period to allow for excretion of all but a small percentage of the 1251. Approximately 25% of the 1311 is liberated by catabolism during the period of the experiment. Under these circumstances passage of 1311 albumin into the gut at any time during the experiment would be expected to raise the 131:125 ratio above that found for the urine accumulated over the same period. EXPERIMENTAL Two iodine isotopes having sufficiently different physical characteristics to permit independent estimation in a mixed sample (Cohen and Freeman, 1960) were used in these experiments. 131lodine was used to label normal human albumin and rat albumin (McFarlane, 1958) . Ion exchange resin (Amberlite IRA 400 Cl) was fed by mouth; in human experiments 10 g. (damp weight) was taken every four hours except for the 2 a.m. dose which was omitted. Resin was taken for 24 hours before the injection of radioactivity, and continued for the duration of the experiment. In rats the ion exchange resin was mixed with the diet and fed in the normal manner, so the precise dose was not known; however, resin loading per gram body weight was estimated to be about three times the human dose. Non-radioactive sodium iodide was given by mouth before and during the experiment to block thyroid uptake; because of the presence of resin an increased amount (200 mg. per day) was given in divided doses between intakes ofresin. External counting indicated that about 1% of the dose of radioactivity had been taken up by the thyroid.
In the human experiments, 24 hours after the first dose of resin by mouth about 60 ,uc. of 1311-albumin mixed with about 20 uc. of Na 1251 was injected intravenously. All urine and faeces were collected, and the activity measured by scintillation counting in a well-type detector. Faecal samples were emulsified with a minimum volume of water to a thick slurry; if the resin tended to sediment, either potato starch or Sephadex G 75 was added to thicken the mixture. In order to recover samples of resin from the faeces, washing with water was used instead of adding starch. The rats, after the intravenous injection of radioactive material, were kept in a metabolism cage placed over a rapidly spinning disc covered with filter paper. This caused the faeces to be thrown off sideways so that contamination with urine was minimal. Blood samples were taken daily in the human experiments, and gave values for the catabolism of albumin consistent with those previously reported (Cohen, Freeman, and McFarlane, 1961 namely, either no significant quantity of albumin passes into the gut, or the resin is unable to absorb and retain even part of the non-protein 1311 radioactivity formed from it. Although the resin has been shown to lose a considerable part of any 1311 iodide originally bound to it during passage through the gut the latter possibility still appears unlikely, especially as resin recovered from the faeces was shown to have retained some capacity for trapping iodide. If some part of the 1311 iodide which would certainly be formed from any 131J albumin passing into the gut would in fact be retained in the faeces, and also because it has been shown with certainty that the resin is unable to retain all previously adsorbed 1311 iodide, it seems safe to conclude that the method of Jeejeebhoy and Coghill (1961) cannot be used to measure passage of albumin into the gut or to show whether it occurs in a particular case.
The only aspect of the present experiments which is difficult to interpret is the finding of rather higher ratios of 1251 to 1311 in the faeces as compared with the same ratio in the urine. Just possibly the higher ratio in the faeces might be due to uneven distribution of resin in the gut resulting from its intermittent administration by mouth. In these circumstances the passage of sufficient 1311 albumin into the gut to equalize the ratio with that in the urine would have been missed if in fact it had occurred. On the other hand, if albumin does not pass into the gut then the observed faecal and urine 1251:131I ratios may be the result of the catabolism of a part of the albumin in the kidneys. However this problem may ultimately be resolved, unless substantial catabolism of albumin by the kidneys can be established the present evidence must tend to invalidate any theory involving passage of more than very small amounts of albumin into the gut. Above all it should be noted that whether or not albumin passes into the gut in normals is strictly irrelevant to the main purpose of this investigation which was to examine the validity of the method of Jeejeebhoy and Coghill (1961) .
Finally it may be noted that the increased proportion of activity found on the resin in patients where an increased leak of albumin (Jeejeebhoy and Coghill, 1961 ) is postulated could be explained by altered conditions (of bulk, mobility, and pH) inside the bowel which favoured retention of activity by the resin. Alternatively there may in fact be a large leakage of albumin into the gut in these cases.
The technique described here using sodium 1251 iodide, which for optimum results should be infused for several days, should differentiate clearly between these hypotheses.
CONCLUSIONS
In normal subjects and in rats experiments with 131iodine-labelled albumin given intravenously and amberlite IRA 400 by mouth provide no evidence in favour of leakage of albumin into the gut; however, because of the inefficiency of the resin as a trap for iodide this does not prove conclusively that some leakage may not occur.
The faecal recovery of radioactivity after injection of labelled albumin only does not provide the basis for a quantitative estimation of the amount of albumin which may pass into the gut in certain pathological conditions.
